Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

ADVENTITIA

Financiado

Cerrado

The arterial adventitia a critical actor in atherosclerotic plaque progression...

The arterial adventitia a critical actor in atherosclerotic plaque progression and stability? Background: The clinical outcome of cardiovascular diseases such as myocardial infarction and stroke is generally caused by rupture or erosion of an atherosclerotic plaque. While the contribution of the plaque intima and media to... ver más

31/07/2010

UNIVERSITEIT MAAST...

159K€

Presupuesto del proyecto: 159K€

Líder del proyecto

UNIVERSITEIT MAASTRICHT No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo FP7 notifico la concesión del proyecto el día 2010-07-31 No tenemos la información de la convocatoria

0% 100% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

UNIVERSITEIT MAASTRICHT

0.00€ | Lider

Proyectos interesantes

PID2019-108568RB-I00

Medical Technol...

Cardiology

230K€ Cerrado

SAF2013-42962-R

Medical Technol...

Cardiology

460K€ Cerrado

SAF2016-75580-R

Medical Technol...

Cardiology

266K€ Cerrado

ATHEROREMO

Medical Technol...

Public Health

15M€ Cerrado

SAF2016-79593-P

Medical Technol...

Nanotechnology

Cerrado

VIA

Medical Technol...

Cardiology

8M€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Líder del proyecto

UNIVERSITEIT MAASTRICHT No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 159K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Background: The clinical outcome of cardiovascular diseases such as myocardial infarction and stroke is generally caused by rupture or erosion of an atherosclerotic plaque. While the contribution of the plaque intima and media to plaque initiation and progression are well acknowledged, that of the arterial perivascular tissue, the adventitia, is not established yet. Hypothesis: Adventitial inflammation, which is partially modulated by adipocyte activity, profoundly impacts plaque progression and stability and that modulation of this process could be a new therapeutic approach to improve the resilience of a plaque to rupture. Key objectives: 1) Determine the contribution of adventitial activation of adipocytes to plaque progression and stability in vivo in our model of collar aided carotid artery atherosclerosis, which affords flow induced atherosclerotic lesions, accessible to local intervention. Specific adipocyte activators will be applied, either systemically or focally and its effect on plaque development tested. Likewise, the effect of specific inhibitors of adipocytes activation will be determined. 2) Assess the possible activation pathways in situ and the culprit actors responsible for the plaque destabilizing effect. Implications: The results of these studies will not only increase our insight in the pivotal role of the adventitia in atherosclerotic plaque development and stability, but also is expected to lead to new targets and therapeutic modalities in the treatment of cardiovascular diseases. The applicant finished her Ph.D. summa cum laude at the CSIC (Spanish Research Council) in Seville and is currently Post-doctoral fellow. The mutual intentions of creating a long-term collaboration between the two institutes furthermore contributes to the impact the fellowship will have on EU scientific excellence.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores